Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Not Confirmed
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Not Confirmed
Not Confirmed
10-12 December, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
10-12 December, 2025
Saudi International Ex...Saudi International Expo
Industry Trade Show
Not Confirmed
10-12 December, 2025
Antibody EngineeringAntibody Engineering
Industry Trade Show
Not Confirmed
10-12 December, 2025
Digital content

10 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-secures-additional-key-us-patent-claims-for-bravyl-oral-fasudil-in-treating-als-including-reducing-neurofilament-light-nfl-302347407.html

09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-reveals-breakthrough-findings-showing-spread-of-toxic-tdp-43-pathology-greatly-reduced-in-bravyl-oral-fasudil-treated-als-patients-302324081.html

12 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-completes-patient-recruitment-for-high-dose-cohort-of-als-study-302299710.html

21 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-announces-several-patents-granted-by-uspto-strengthening-the-companys-intellectual-property-position-in-als-302280979.html

08 Jul 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/woolsey-pharmaceuticals-announces-treatment-of-first-patient-with-higher-dose-bravyl-in-the-real-amyotrophic-lateral-sclerosis-als-study-nct05218668-302190827.html

25 Nov 2019
// BUSINESS WIRE
ABOUT THIS PAGE